Avita Health System Expanded Oncology Services
The Ontario health system has added advanced radioligand and immunotherapy options to its cancer care program.
Updated on Sept. 24, 2026 in Cancer
Live Poll
Do you believe having advanced cancer treatments available locally improves patient care outcomes?
Avita Health System has incorporated Pluvicto radioligand therapy and bispecific antibody immunotherapy into its oncology services. These advanced treatments are now available to patients at the Jody M. Baker Cancer Center at the Avita Ontario South Campus.
Why it matters
This expansion allows local residents to access specialized cancer treatments without the need to travel to distant major medical centers. The program aims to streamline care delivery for patients managing complex treatment regimens.
Avita employs PSMA PET imaging to evaluate patients for Pluvicto, an FDA-approved radioligand therapy that targets prostate cancer cells. This expansion represents a significant increase in local treatment complexity vs. historical service offerings.
The players
Avita Health System
This is a regional healthcare provider that operates the Ontario South Campus and provides specialized medical services to the community.
Jody M. Baker Cancer Center
This facility is the dedicated oncology unit within the Avita Health System where these new treatments are administered.
The details
A multidisciplinary team consisting of oncologists, pharmacists, and physicists now coordinates the delivery of these complex immunotherapies. The system utilizes advanced treatment planning and patient education to support individuals throughout their care.
Timeline
September 23, 2026: Avita Health System announced the expansion of cancer services.
The Big Picture
The integration of this technology follows the industry-wide shift toward decentralized specialty care, mirroring the broader adoption of the FDA-approved Pluvicto radioligand therapy protocol. This transition marks a departure from centralized models by enabling local health systems to administer complex, radiation-targeted immunotherapies.
Patients in the area can now receive specialized cancer treatments closer to home, reducing the logistical burden of traveling to larger urban medical centers. Individuals interested in these new therapies can coordinate with the oncology team at the Jody M. Baker Cancer Center for evaluation.
The takeaway
This expansion broadens the range of specialized oncology treatments available within the Ontario community. Patients should consult their care team to determine if these specific immunotherapies are appropriate for their treatment plan.
Further reading
For additional context on regional oncology advancements, visit Cancer.
More information
Find complete details on the new offerings on the Avita Health System oncology services information page.
Source note: This article includes information reported by Galion Inquirer.
Live Poll
Do you believe having advanced cancer treatments available locally improves patient care outcomes?
